Home / Import refusals / SCS-3091426-8/10002/1

FDA Import Refusal SCS-3091426-8/10002/1 — Pfizer Limited

Pfizer Limited — FEI 3012284255

The FDA refused shipment SCS-3091426-8/10002/1 from Pfizer Limited (India) on May 4, 2026. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
May 4, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
61JCC08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
Charges
75

Other import refusals

  • SCS-4181567-8/50002/1 (Tue May 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-4001046-3/40002/1 (Fri Apr 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9426366-0/140003/1 (Fri Feb 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7840099-9/30003/1 (Mon Dec 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7960317-9/40003/1 (Mon Nov 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources